Skip to content

GeoVax Labs, Inc.

GOVX

CIK 0000832489 · Pharmaceutical Preparations · Nasdaq

  • DAUPHIN TECHNOLOGY INC (until 2006-09-20)
← back to feed
Revenue (TTM)
$2.49M
−37.1% YoY Q1 May 2026
Net Income (TTM)
−$22.31M
+14.1% YoY Q1 May 2026
EPS Diluted (TTM)
—
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-902.7%
Q1 May 2026
Net Margin
-896.2%
Q1 May 2026
Free Cash Flow (TTM)
−$18.97M
Q1 May 2026
Cash
$1.27M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
3.47M sh
Q1 May 2026

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings